HIV/AIDS Monitor: Tracking Aid Effectiveness

Key Accomplishments

Billions of dollars in aid started flowing to developing countries in the early 2000s to confront HIV/AIDS but relatively little was known about how these dollars were being used and to what end. The HIV/AIDS Monitor was designed to help fill this knowledge gap by tracking and analyzing key features of the way aid for HIV/AIDS is allocated and disbursed, while identifying lessons relevant to broader questions about the effectiveness of development assistance.

From 2006 until 2010, the HIV/AIDS Monitor focused on the performance of three HIV/AIDS donor programs—the U.S. government's President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund for AIDS, Tuberculosis and Malaria (The Global Fund), and the World Bank's Multi-Country AIDS Program (MAP). The Center for Global Development’s HIV/AIDS Monitor team, led by Nandini Oomman (with support from the Bill & Melinda Gates Foundation, The International Development Research Center, Canada (IDRC), The David & Lucile Packard Foundation, the Swedish International Development Cooperation Agency and the Rockefeller Foundation) examined key issues in the design, delivery and management of these donor programs, and provided timely analyses to improve the efficiency and effectiveness of each initiative. For more information on the original design of the HIV/AIDS Monitor please refer to our Concept Note (PDF).

Global Level and Country-based reports on the HIV/AIDS programs, produced in collaboration with partners on the ground in Mozambique, Uganda and Zambia, provided evidence-based policy recommendations to the top donors. Over the course of the initiative, with ongoing research and active outreach of its findings, the Monitor team accomplished the following at the global and country level:

Influenced PEPFAR and other donor policies and practices
CGD played an important role in informing and shaping the policies of the three donors on an ongoing basis over the last four years. The HIV/AIDS Monitor's recommendations are now reflected in donor current strategies and actions. For example:
- PEPFAR's Five Year Strategy and the new U.S. Global Health Initiative stress a transition to country ownership and strengthening health systems through a coordinated, whole-of-government approach based on the recommendation that PEPFAR should make host governments a truer partner in programs and to focus on health systems.
- The World Bank's Agenda for Action subsequently incorporated a focus on building governments' financial management capacity based on the recommendation that the World Bank Multi-Country AIDS Program (MAP) should focus on improving health information systems.
- The Global Fund changed its reporting requirements for recipients from every 3 months to every 6 months following this recommendation from the HIV/AIDS Monitor report on performance-based funding.
Increased PEPFAR’s Transparency and Release of Data
An ongoing push throughout the Monitor research recommendations has been the importance of accurate, transparent and readily available data to inform programming at the donor and country level. Our 2008 report, Numbers Behind the Stories, which analyzed newly available PEPFAR data not otherwise public, stressed the importance of making funding data widely available. Our report argues that knowledge of official data on obligations to recipients of the funds improves transparency and allows for accurate analyses of its cost-effectiveness. Knowledge from this report, as well as our other reports that looked more specifically at issues surrounding the availability of programmatic data, informed Nandini Oomman’s memo to President Obama encouraging him to allow for the more public release of PEPFAR data. Evidence from updated PEPFAR policies shows that the U.S. government is heeding this advice—more data on financial obligations by the U.S. Government to specific countries are being released on the website (they were previously redacted) and PEPFAR’s Five-Year Strategy 2009-2014 cites "working to expand publicly available data" as a key initiative in its next five years, though types of data (financial, programmatic, etc.) have yet to be specified.
Informed Congressional Oversight of PEPFAR’s bilateral and multilateral global AIDS Funding
The HIV/AIDS Monitor team provided senior Congressional staff (Democrat and Republican) with study findings and recommendations to inform the creation of new policies (such as reauthorization of PEPFAR), new strategies (PEPFAR II) and new U.S.G global health initiatives (U.S. Global Health Initiative), and monitor the progress of current policies as legislated. In addition, the Government Accountability Office (GAO) team tasked by Congress with oversight of PEPFAR routinely consulted CGD experts on Monitor findings to frame questions for their studies and to use our research results as additional evidence in their reports. In the words of a GAO staff person, “The HIV/AIDS Monitor publications helped us understand the issues surrounding PEPFAR implementation…which in turn helped us define the scope of our research” The Institute of Medicine (IOM) team charged by Congress with the evaluation of PEPFAR II also consulted with the HIV/AIDS Monitor team in preparing background information for the Committee that will plan and implement the evaluation.
Increased the visibility of AIDS funding and global health as a key aid effectiveness issue at the global and country level
The HIV/AIDS Monitor built a brand on the topic of aid effectiveness for AIDS and Global Health funding at the global and country level. By documenting donor policies and practices and sharing these widely with different audiences in the U.S. and globally, the HIV/AIDS Monitor has raised the importance of this topic through several different channels such as publications, events, and extensive use of the World Wide Web. For example, at the global level, a CGD background report shed light on the workings of, and challenges to, antiretroviral supply chains for developing countries—and triggered supply-chain stakeholders to increase the efficiency of the Global Supply Chain and another CGD background report contributed to the debate about increasing aid effectiveness by describing how the three donors take program performance into consideration when making final decisions about funding . At the country level, such as in Zambia, CGD’s report, Following the Funding for HIV/AIDS, was reported (by a donor official) to have influenced the design and process of tracking the HIV/AIDS funds within the National Health Accounts in the Ministry of Health and in the drafting of the International Health Partnership position paper of MOH. In Uganda, the results of the gender theme were presented in parliament and at the health sector review meeting at the invitation of the Director General. A senior official in the MOH reported that lessons learnt from the HIV/AIDS Monitor have influenced their dialogues with donors.

Today, following many of the HIV/AIDS Monitor's recommendations, bilateral and multilateral donors continue to support the HIV/AIDS response in the developing world, moving away from a vertical disease approach to one that focuses on strengthening a country’s capacity to respond to HIV/AIDS as part of a broader set of global health priorities.

The Center for Global Development continues to track ongoing policy changes related to the HIV/AIDS Monitor team's findings and follows the effectiveness of global health development assistance through its research, blogs and global health policy newsletter that is published monthly.

Newest Popular Experts Publications Events Multimedia Selected Works

Think Long Term: How Global AIDS Donors Can Strengthen the Health Workforce in Africa - Sep 9, 2010

For the past decade, global AIDS donors have responded to HIV/AIDS in sub-Saharan Africa as an emergency and have mobilized health workers from weak and understaffed workforces. They must begin to address the long-term problems underlying the shortages and the effects of their efforts on the...
HIV/AIDS Donors and Africa’s Health Workforce: Nandini Oomman - Sep 8, 2010

My guest this week is Nandini Oomman, director of the Center for Global Development’s HIV/AIDS Monitor. Her team has just released a new report, Zeroing In: AIDS Donors and Africa’s Health Workforce, which looks at how AIDS programs could be better designed to strengthen the capacity of nurses...
Zeroing In: AIDS Donors and Africa’s Health Workforce - Aug 26, 2010

This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS...
What Is Country Ownership Anyway? Rethinking Global Health Partnerships - Jun 21, 2010

The concept of country ownership has become increasingly visible in donor policy and strategy, yet definitions vary and there is little clarity and great diversity in how this concept is articulated and practiced by donor and recipient countries. Health experts from Ethiopia, Mozambique, Uganda and...
Making HIV Prevention Work (Really): An Incentive-based approach, with a specific focus on couples’ voluntary counseling and testing - Jun 8, 2010

How can we stem the tide of the HIV epidemic? The impressive scale up of international spending on HIV treatment has led to significant declines in morbidity and mortality from HIV/AIDS. However, as these impressive gains have gone unmatched by corresponding decreases in the incidence of new...
Turning the Tide Through Better Prevention: Mead Over on the AIDS Transition - May 25, 2010

Even as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global...
Taking Prevention to Scale: Lessons from India's Mukta Project - May 25, 2010

The "Mukta" (meaning "Freedom") Project, as it is locally known, is an initiative of Pathfinder International, a partner of the Gates Foundation/Avahan Project in India. Pathfinder International works in 10 districts of Maharashtra state in India to reduce the prevalence of STIs and HIV/AIDS among...
Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance - May 10, 2010

Billions of dollars have been allocated to fight HIV/AIDS in poor countries over the past decade, yet less than half of those requiring treatment receive it, and for every two people put on treatment, five more become newly infected. Economic pressures and competing global health priorities are...
Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance - Apr 13, 2010

Billions of dollars have been allocated to fight HIV/AIDS in poor countries over the past decade, yet less than half of those requiring treatment receive it, and for every two people put on treatment, five more become infected. Donors have to do more with available funds. Now is the time to link...
HIV/AIDS Monitor: Are Funding Decisions Based on Performance? - Apr 6, 2010

This report examines the use of performance-based funding (PBF) among the big three funders of HIV/AIDS programs in developing countries: the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS Tuberculosis and Malaria, and the World Bank’s Multi-Country...

CGD Special Discussion with David Gergen on Obama's Global Development Policy (Event Video) - Jan 17, 2009

Director of the Center for Public Leadership at the John F. Kennedy School of Government at Harvard University, editor-at-large at U.S. News & World Report, and a senior political analyst for CNN, David Gergen joined CGD president Nancy Birdsall, and CGD senior fellows who authored essays in our...
Costs and Causes of Zimbabwe's Crisis - Jul 20, 2005

Zimbabwe has experienced a precipitous collapse in its economy over the past five years. The government blames its economic problems on external forces and drought. We assess these claims, but find that the economic crisis has cost the government far more in key budget resources than has the donor...
Millions Saved: Proven Successes in Global Health - Nov 30, 2004

Millions Saved: Proven Success in Global Health is about part of that success story: 17 cases in which large-scale efforts to improve health in developing countries have succeeded - saving millions of lives and preserving the livelihoods and social fabric of entire communities.
Making Markets for Vaccines: Ideas to Action - Apr 7, 2005

Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
Following the Funding for HIV/AIDS: A Comparative Analysis of the Funding Practices of PEPFAR, the Global Fund and World Bank MAP in Mozambique, Uganda and Zambia - Oct 10, 2007

Donor funding for HIV/AIDS has skyrocketed in the last decade: from US$ 300 million in 1996 to US$ 8.9 billion in 2006. Yet, surprisingly little is known about how this money is spent. Following the Funding for HIV/AIDS, by CGD's HIV/AIDS Monitor team, analyzes the policies and practices of the...
Zeroing In: AIDS Donors and Africa’s Health Workforce - Aug 26, 2010

This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS...
HIV/AIDS Monitor: Are Funding Decisions Based on Performance? - Apr 6, 2010

This report examines the use of performance-based funding (PBF) among the big three funders of HIV/AIDS programs in developing countries: the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS Tuberculosis and Malaria, and the World Bank’s Multi-Country...
New PEPFAR Data: The Numbers Behind the Stories - Apr 17, 2008

The President's Emergency Plan for AIDS Relief (PEPFAR) is the single largest funder of global AIDS relief programs, but it does not regularly release data on how its money is spent. In this report, CGD's HIV/AIDS Monitor Team analyzes a newly available dataset of PEPFAR funding. They find, among...
Prevention Failure: The Ballooning Entitlement Burden of U.S. Global AIDS Treatment Spending and What to Do About It - Working Paper 144 - May 5, 2008

U.S. global AIDS spending is helping to prolong the lives of more than a million people, yet this success contains the seeds of a future crisis. Escalating treatment costs coupled with neglected prevention measures mean that AIDS spending is growing so rapidly that it threatens to squeeze out U.S....
Global HIV/AIDS and the Developing World - Jun 15, 2006

HIV/AIDS is one of the largest challenges facing the global community. The disease has reduced life expectancy by more than a decade in the hardest hit countries and slashed productivity, making it even harder for poor countries to escape poverty. Global HIV/AIDS and the Developing World, a CGD...

James Habyarimana, Non-Resident Fellow
James Habyarimana joined the center in September 2004 just after completing his doctoral studies in development economics at Harvard University. His main research in graduate school touched on the role of public finance in improving educational outcomes in Zambia, the disease environment as a...
Mead Over, Senior Fellow
Mead Over applies economics and statistics in the search for more effective, efficient, and pro-poor health policies in developing countries. His newest book is Achieving an AIDS Transition: Preventing Infections to Sustain Treatment.

Think Long Term: How Global AIDS Donors Can Strengthen the Health Workforce in Africa - Sep 9, 2010

For the past decade, global AIDS donors have responded to HIV/AIDS in sub-Saharan Africa as an emergency and have mobilized health workers from weak and understaffed workforces. They must begin to address the long-term problems underlying the shortages and the effects of their efforts on the...
Zeroing In: AIDS Donors and Africa’s Health Workforce - Aug 26, 2010

This report focuses on the workforce strengthening strategies of three of the major HIV/AIDS donors—the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and the World Bank’s Africa Multi-country HIV/AIDS...
Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance - Apr 13, 2010

Billions of dollars have been allocated to fight HIV/AIDS in poor countries over the past decade, yet less than half of those requiring treatment receive it, and for every two people put on treatment, five more become infected. Donors have to do more with available funds. Now is the time to link...
HIV/AIDS Monitor: Are Funding Decisions Based on Performance? - Apr 6, 2010

This report examines the use of performance-based funding (PBF) among the big three funders of HIV/AIDS programs in developing countries: the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS Tuberculosis and Malaria, and the World Bank’s Multi-Country...
Going Beyond Gender as Usual: Why and How Global HIV/AIDS Donors Can Do More for Women and Girls - Aug 19, 2009

Few people doubt that gender inequality influences the spread of HIV/AIDS, yet public health efforts tend to focus on changing individual behavior rather than addressing structural factors—social, economic, physical and political—that influence the spread and effects of HIV and AIDS. ...
Moving Beyond Gender as Usual - Jun 29, 2009

Gender inequality drives the HIV epidemic, increasing the burden on women and girls and undermining the global response to the disease. A new HIV/AIDS Monitor report finds that despite well-meaning language and admirable broad goals, three of the biggest HIV/AIDS funders have yet to translate...
Cross-Country Data on AIDS Treatment and HIV Prevalence in 2006-07 - Jun 5, 2009

This dataset compiles selected global variables on AIDS and its treatment and prevention. The data are in the format developed by the Stata statistical software corporation and are intended for use with Over and McCarthy's AIDSCost package for the purpose of projecting the future budgetary cost of...
Projecting the Future Budgetary Cost of AIDS Treatment (Manual, Software Package, and Dataset) - Jun 5, 2009

CGD senior fellow Mead Over and Owen McCarthy offer a users' manual and Stata software to help students and instructors of public health, development economics, or health economics to project the future budgetary cost of AIDS treatment in poor countries and to explore the many factors affecting the...
UNAIDS: Preparing for the Future - Mar 26, 2009

This report by the UNAIDS Leadership Transition Working Group argues that the new executive director of the Joint United Nations Programme on HIV/AIDS should focus on a few essential tasks: promoting evidence-based prevention and treatment strategies, ensuring that UN agencies adequately support...
AIDS Treatment in South Asia: Equity and Efficiency Arguments for Shouldering the Fiscal Burden When Prevalence Rates Are Low - Working Paper 161 - Feb 26, 2009

Senior fellow Mead Over estimates the effect of AIDS on poverty in South Asia and analyzes public policy options to help the region’s predominantly private health care systems meet the challenge of treating AIDS. He finds that South Asian governments should play a larger role in AIDS treatment...
Releasing PEPFAR Data to Improve Effectiveness of HIV/AIDS Spending - Dec 1, 2008

Nandini Oomman, director of CGD's HIV/AIDS Monitor, calls on President-elect Obama to push PEPFAR (the President's Emergency Plan for AIDS Relief)to release official data on obligations to prime partners, subpartners, and program areas to improve transparency and accountability.
Seizing the Opportunity on AIDS and Health Systems - Aug 4, 2008

Donors spend billions of dollars to fight HIV/AIDS in developing countries, but poor integration between donors and host country health systems risks undermining international efforts to prevent and treat AIDS. In this analysis, CGD’s HIV/AIDS Monitor argues that donors need to pay more...
Prevention Failure: The Ballooning Entitlement Burden of U.S. Global AIDS Treatment Spending and What to Do About It - Working Paper 144 - May 5, 2008

U.S. global AIDS spending is helping to prolong the lives of more than a million people, yet this success contains the seeds of a future crisis. Escalating treatment costs coupled with neglected prevention measures mean that AIDS spending is growing so rapidly that it threatens to squeeze out U.S....
New PEPFAR Data: The Numbers Behind the Stories - Apr 17, 2008

The President's Emergency Plan for AIDS Relief (PEPFAR) is the single largest funder of global AIDS relief programs, but it does not regularly release data on how its money is spent. In this report, CGD's HIV/AIDS Monitor Team analyzes a newly available dataset of PEPFAR funding. They find, among...
PEPFAR Reauthorization: Improving Transparency in U.S. Funding for HIV/AIDS - Nov 12, 2007

The President's Emergency Plan for AIDS Relief (PEPFAR) provides more than $5 billion per year to prevent and treat HIV/AIDS. Exactly how is that money spent? Donors, recipients, and even PEPFAR staff are often left guessing, because much of the extensive data the U.S. government collects on the...
Following the Funding for HIV/AIDS: A Comparative Analysis of the Funding Practices of PEPFAR, the Global Fund and World Bank MAP in Mozambique, Uganda and Zambia - Oct 10, 2007

Donor funding for HIV/AIDS has skyrocketed in the last decade: from US$ 300 million in 1996 to US$ 8.9 billion in 2006. Yet, surprisingly little is known about how this money is spent. Following the Funding for HIV/AIDS, by CGD's HIV/AIDS Monitor team, analyzes the policies and practices of the...
A Trickle or a Flood: Commitments and Disbursement for HIV/AIDS from the Global Fund, PEPFAR, and the World Bank's Multi-Country AIDS Program (MAP) - Mar 5, 2007

In response to both public health imperative and unprecedented political pressure, aid to fight HIV/AIDS has increased massively in recent years: global funding to combat the disease in low- and middle-income countries has more than tripled since 2001, from $2.1 billion to an estimated $8.9 billion...
Challenges and Opportunities for the New Executive Director of the Global Fund: Seven Essential Tasks - Oct 26, 2006

In its first four years, the Global Fund to Fight AIDS, Tuberculosis and Malaria has become one of the most important aid agencies in the world. As the Global Fund undergoes its first leadership transition, this CGD Working Group Report identifies seven tasks for the new Executive Director,...
Global HIV/AIDS and the Developing World - Jun 15, 2006

HIV/AIDS is one of the largest challenges facing the global community. The disease has reduced life expectancy by more than a decade in the hardest hit countries and slashed productivity, making it even harder for poor countries to escape poverty. Global HIV/AIDS and the Developing World, a CGD...
Costs and Causes of Zimbabwe's Crisis - Jul 20, 2005

Zimbabwe has experienced a precipitous collapse in its economy over the past five years. The government blames its economic problems on external forces and drought. We assess these claims, but find that the economic crisis has cost the government far more in key budget resources than has the donor...
Addressing the Challenge of HIV/AIDS: Macroeconomic, Fiscal and Institutional Issues - Working Paper 58 - Apr 26, 2005

After decades of neglect the HIV/AIDS epidemic has rightly become one of the highest priorities on the global agenda. Funding pledges from the donors have doubled resource commitments between 2002 and 2004 to over $6 billion. That surge in funding belies the volatile nature of contributions to...
Making Markets for Vaccines - Ideas to Action (Brief) - Apr 7, 2005

New medicines are usually financed by a mixture of public funding by governments, philanthropic giving, and investment by private firms. Private investment is especially important in paying for and managing the later stages of clinical trials, regulatory approval, and investment in manufacturing...
Making Markets for Vaccines: Ideas to Action - Apr 7, 2005

Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
Millions Saved: Proven Successes in Global Health - Nov 30, 2004

Millions Saved: Proven Success in Global Health is about part of that success story: 17 cases in which large-scale efforts to improve health in developing countries have succeeded - saving millions of lives and preserving the livelihoods and social fabric of entire communities.
Millions Saved: Proven Successes in Global Health (Brief) - Nov 30, 2004

This Brief is based on the CGD book Millions Saved: Proven Successes in Global Health. The book book features 17 success stories. These cases describe some large-scale efforts to improve health in developing countries that have succeeded - saving millions of lives and preserving the livelihoods...
HIV/AIDS and the Accumulation and Utilization of Human Capital in Africa - Working Paper 2 - Jan 2, 2002

This paper outlines the likely effects of the AIDS pandemic in Africa on the continent's ability to produce education and use it effectively for growth and poverty reduction.

What Is Country Ownership Anyway? Rethinking Global Health Partnerships - Jun 21, 2010
The concept of country ownership has become increasingly visible in donor policy and strategy, yet definitions vary and there is little clarity and great diversity in how this concept is articulated and practiced by donor and recipient countries. Health experts from Ethiopia, Mozambique, Uganda and...
Making HIV Prevention Work (Really): An Incentive-based approach, with a specific focus on couples’ voluntary counseling and testing - Jun 8, 2010
How can we stem the tide of the HIV epidemic? The impressive scale up of international spending on HIV treatment has led to significant declines in morbidity and mortality from HIV/AIDS. However, as these impressive gains have gone unmatched by corresponding decreases in the incidence of new...
Taking Prevention to Scale: Lessons from India's Mukta Project - May 25, 2010
The "Mukta" (meaning "Freedom") Project, as it is locally known, is an initiative of Pathfinder International, a partner of the Gates Foundation/Avahan Project in India. Pathfinder International works in 10 districts of Maharashtra state in India to reduce the prevalence of STIs and HIV/AIDS among...
Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance - May 10, 2010
Billions of dollars have been allocated to fight HIV/AIDS in poor countries over the past decade, yet less than half of those requiring treatment receive it, and for every two people put on treatment, five more become newly infected. Economic pressures and competing global health priorities are...
Lessons Learned in Addressing HIV Infection among Haitian Adolescents - Dec 4, 2009
Haitian girls and young women living in Port-au-Prince are particularly vulnerable to HIV infection, with a much higher HIV prevalence than the general population. Since the early 1980s, the Haitian Study Group on Kaposi's Sarcoma and Opportunistic Infections (GHESKIO) has provided care for...
Beyond Gender as Usual: How HIV/AIDS Donors Can Do More for Women and Girls - Jul 1, 2009
Today in sub-Saharan Africa, 61 percent of all people infected with HIV are women, and women age 15-24 are the most vulnerable to infection. Women and girls are at greater risk of HIV infection in part due to power imbalances between women and men that limit the social and economic choices that...
Why HIV/AIDS is Still Exceptional - Apr 20, 2009
Please join us for a discussion with Dr. Alan Whiteside, where he will examine the origins of AIDS exceptionalism and how it has helped and hindered our response to the epidemic. Whiteside will ask if exceptionalism is still a useful concept in light of our current knowledge about the epidemic, the...
Circumcision, Information, and HIV Prevention - Feb 24, 2009
Abstract: HIV is a significant problem in sub-Saharan Africa and while many types of HIV prevention strategies have been adopted, there has been limited success with affecting behavior change. One recent potential HIV prevention strategy is male circumcision. Recent randomized control trials in...
How are HIV/AIDS donors interacting with national health systems? - Aug 6, 2008
Abstract: Health systems in Mozambique, Uganda and Zambia--as in other African countries--face major challenges that have hampered the provision of health services for decades. But in recent years they have received renewed attention, as large sums of AIDS money flow into the countries from global...
Global Development May Meetup - May 8, 2008
On Thursday, May 8th we will be joined by Steve Rosenzweig, Program Coordinator for the HIV/AIDS Monitor at the Center for Global Development. Rosenzweig will discuss his recent trip to Uganda, where he coordinated a workshop with the Monitor's African research partners from Mozambique, Zambia, and...
What Are Donors Doing with AIDS Money? A Comparative Analysis of PEPFAR, Global Fund, and World Bank Funding in Mozambique, Uganda and Zambia - Oct 10, 2007
How do AIDS donors provide money to countries affected by AIDS? Who receives this funding, and how is it spent? Is funding disbursed quickly and predictably? Does it build capacity? In a new paper from the HIV/AIDS Monitor, Nandini Oomman, Michael Bernstein and Steven Rosenzweig address these...
Can Public-Private Partnerships Help Stop AIDS in Africa? Lessons from Botswana - Jun 6, 2007
An innovative model for fighting HIV/AIDS in Africa is being piloted in Botswana through a public-private partnership involving the Government of Botswana, the Bill & Melinda Gates Foundation and Merck & Co., Inc. The partnership is intended to help Botswana achieve an "AIDS-Free Generation by...
A European Perspective on the Future of Global AIDS Programs:
A Conversation with Five AIDS Ambassadors - Jan 26, 2007
Five European AIDS ambassadors will discuss lessons learned from global AIDS programs, and opportunities and challenges for European-U.S. collaboration. After their opening presentations, the ambassadors will join audience members in breakout groups on: 1) HIV prevention, 2) Gender and HIV/AIDS,...
Future Directions for the Global Fund - Dec 14, 2006
The Global Fund to Fight AIDS, Tuberculosis and Malaria is at an important juncture as Richard Feachem completes his tenure as the first executive director and the Global Fund evolves from an innovative start-up to a mature organization. What are the most critical challenges in this new phase? How...
Do U.S. Free Trade Agreements Limit Access to Medicines?
Exploring the Impact of the Proposed U.S.-Thailand Free Trade Agreement on Availability of Generic HIV/AIDS Drugs - Oct 16, 2006
Thailand and the United States began negotiating a free trade agreement in 2004. Although negotiations are now stalled, the latest version of the FTA would restrict Thailand's ability to produce or import generic AIDS drugs. Limpananont argues that these restrictions could have a significant...
A New UN Agency for Women: Who Needs It? - Sep 7, 2006
Gender inequality is a widely recognized problem across the world. Its effects can often be deadly, a fact most evident in the greater vulnerability of girls and women to HIV/AIDS. UN Special Envoy for HIV/AIDS in Africa, Stephen Lewis, will argue that a new UN agency for women is necessary to...
Where is the Comparative Advantage?
The Global Fund and World Bank HIV/AIDS Programs Moving Forward - Feb 7, 2006
CGD and Friends of the Global Fight co-hosted this panel discussion on the World Bank and Global Fund HIV/AIDS programs. Speakers included Christoph Benn, Director of External Relations, Global Fund to Fight AIDS, Tuberculosis and Malaria; Jonathan Brown, Operations Advisor, Global HIV/AIDS...
Is It Really Working? HIV/AIDS, Global Initiatives,
and the Pressing Challenge of Evaluation - Jan 23, 2006
CGD hosted a panel discussion on HIV/AIDS and evaluation. Speakers included Martha Ainsworth, World Bank; Ruth Levine, Center for Global Development; Michele Orza, Institute of Medicine; and Cyril Pervilhac, World Health Organization.
Private Sector Responses to HIV/AIDS: The Case of Debswana,
Botswana’s Diamond Company - Oct 4, 2005
Bekezela Mbakile, director of the Debswana HIV/AIDS program spoke about the development and implementation for the HIV/AIDS prevention and treatment programs.
HIV/AIDS: Money, Bottlenecks and the Future - Apr 18, 2005
CGD hosted a panel discussion among African ministers of finance, members of the policy and advocacy communities, and senior IMF and World Bank officials on barriers to the disbursement of funds for the HIV/AIDS epidemic in Africa, offering timely insight into a fiercely controversial set of issues.
Fighting AIDS, TB, and Malaria: Innovations and Challenges - Feb 15, 2005
On February 15, 2005 CGD hosted the conference, Fighting AIDS, TB, and Malaria: Innovations and Challenges, that brought together leaders from the World Bank, The Global Fund, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The conference addressed the challenges associated with...
The Long-Run Economic Costs of AIDS: New Results for Kenya - Sep 28, 2004
Shantayanan Devarajan, Chief Economist for South Asia Region at the World Bank presented his paper, The Long-Run Economic Costs of AIDS: New Results for Kenya. The paper discusses the loss in human capital due to HIV/AIDS.
The Global Fund to Fight AIDS, Tuberculosis and Malaria: Potential, Progress, and Challenges for the Future - Jul 1, 2004
Steven Radelet, Senior Fellow, Center for Global Development, presented the results of his analysis of the Global Fund, examining the Fund’s unique structure as a foreign aid institution, its progress to date, and the major challenges it faces going forward.

HIV/AIDS Donors and Africa’s Health Workforce: Nandini Oomman - Sep 8, 2010
My guest this week is Nandini Oomman, director of the Center for Global Development’s HIV/AIDS Monitor. Her team has just released a new report, Zeroing In: AIDS Donors and Africa’s Health Workforce, which looks at how AIDS programs could be better designed to strengthen the capacity of nurses...
Turning the Tide Through Better Prevention: Mead Over on the AIDS Transition - May 25, 2010
Even as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global...
Beyond Gender as Usual (slidecast) - Jul 1, 2009
At a recent launch event for a new report Beyond Gender as Usual: How HIV/AIDS Donors Can Do More for Women and Girls released by the Center for Global Development and the International Center for Research on Women, director of CGD's HIV/AIDS Monitor Nandini Oomman and HIV/AIDS scientist Kim...
What Would the Poor Say: Debates in Aid Evaluation (Presentation) - Feb 13, 2009
In a presentation delivered at NYU's Aid Watch Conference, CGD president Nancy Birdsall, in a session on accountabilty, spoke about Cash on Delivery Aid, a way for donors to transfer money that could make aid-dependent governments accountable for outcomes to their citizens -- instead of for inputs...
CGD Special Discussion with David Gergen on Obama's Global Development Policy (Event Video) - Jan 17, 2009
Director of the Center for Public Leadership at the John F. Kennedy School of Government at Harvard University, editor-at-large at U.S. News & World Report, and a senior political analyst for CNN, David Gergen joined CGD president Nancy Birdsall, and CGD senior fellows who authored essays in our...
HIV/AIDS Monitor (Interview) - Aug 4, 2008
In this video, CGD senior program associate and director of the HIV/AIDS Monitor Nandini Oomman describes her recent finding from the Seizing the Opportunity on AIDS and Health Systems report and outline Monitors future goals.
HIV/AIDS Research in Mozambique (Interview) - Jun 20, 2008
CGD’s HIV/AIDS program works with principle investigators in Uganda, Tanzania, and Mozambique. In this video, Dirce Costa, CGD’s principle investigator in Mozambique describes her research.
HIV/AIDS Research in Zambia (Interview) - Jun 20, 2008
CGD’s HIV/AIDS program works with principle investigators in Uganda, Tanzania, and Mozambique. In this video, Caesar Cheelo, CGD’s principle investigator in Zambia describes his research.
HIV/AIDS Research in Uganda (Interview) - Jun 20, 2008
CGD’s HIV/AIDS program works with principle investigators in Uganda, Tanzania, and Mozambique. In this video, Freddie Ssengooba, CGD’s principle investigator in Uganda describes his research.
What Are Donors Doing with AIDS Money? (Event) - Oct 10, 2007
Center for Global Development senior program associate and director of the HIV/AIDS Monitor Nandini Oomman discusses HIV/AIDS funding by the world's largest AIDS funders – PEPFAR, the Global Fund, and the World Bank.

Donor News and Highlights

Project(RED) generates over $150 million for the Global Fund
The Global Fund and UNAIDS welcome a presidential pardon of a jailed couple in Malawi
A recently approved World Bank project aims to establish a network of high-quality public health laboratories in East Africa